WallStreetZenWallStreetZen

NASDAQ: SCLX
Scilex Holding Co Stock Forecast, Predictions & Price Target

Analyst price target for SCLX

Based on 1 analyst offering 12 month price targets for Scilex Holding Co.
Min Forecast
$12.00+1,293.73%
Avg Forecast
$12.00+1,293.73%
Max Forecast
$12.00+1,293.73%

Should I buy or sell SCLX stock?

Based on 1 analyst offering ratings for Scilex Holding Co.
Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their SCLX stock forecasts and price targets.

SCLX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2023-12-04

1 of 1

Forecast return on equity

Is SCLX forecast to generate an efficient return?
Insufficient data to display

Forecast return on assets

Is SCLX forecast to generate an efficient return on assets?

SCLX revenue forecast

What is SCLX's revenue in the next 3 years based on estimates from 2 analysts?
Avg 1 year Forecast
$95.7M+104.69%
Avg 2 year Forecast
$98.7M+111.25%
Avg 3 year Forecast
$121.3M+159.5%
SCLX's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

SCLX revenue growth forecast

How is SCLX forecast to perform vs Drug Manufacturers - General companies and vs the US market?
Company
49.39%
Industry
8.8%
Market
9.03%
SCLX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
SCLX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

SCLX vs General Drug Manufacturer Stocks

TickerPricePrice TargetUp/downsideConsensus
SCLX$0.86$12.00+1,293.73%Buy
AMRN$0.86N/AN/A
GRFS$6.27$10.50+67.46%Hold
OGN$18.42$20.00+8.58%Buy
BIIB$202.46$284.95+40.74%Buy

Scilex Holding Co Stock Forecast FAQ

Is Scilex Holding Co Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: SCLX) stock is to Buy SCLX stock.

Out of 1 analyst, 0 (0%) are recommending SCLX as a Strong Buy, 1 (100%) are recommending SCLX as a Buy, 0 (0%) are recommending SCLX as a Hold, 0 (0%) are recommending SCLX as a Sell, and 0 (0%) are recommending SCLX as a Strong Sell.

If you're new to stock investing, here's how to buy Scilex Holding Co stock.

What is SCLX's revenue growth forecast for 2024-2026?

(NASDAQ: SCLX) Scilex Holding Co's forecast annual revenue growth rate of 49.39% is forecast to beat the US Drug Manufacturers - General industry's average forecast revenue growth rate of 8.8%, and it is also forecast to beat the US market's average forecast revenue growth rate of 9.03%.

Scilex Holding Co's revenue in 2024 is $46,743,000.On average, 2 Wall Street analysts forecast SCLX's revenue for 2024 to be $15,901,043,413, with the lowest SCLX revenue forecast at $14,659,605,345, and the highest SCLX revenue forecast at $17,142,481,480. On average, 2 Wall Street analysts forecast SCLX's revenue for 2025 to be $16,410,415,257, with the lowest SCLX revenue forecast at $13,145,615,949, and the highest SCLX revenue forecast at $19,675,214,566.

In 2026, SCLX is forecast to generate $20,158,826,986 in revenue, with the lowest revenue forecast at $20,158,826,986 and the highest revenue forecast at $20,158,826,986.

What is SCLX's forecast return on assets (ROA) for 2024-2026?

(NASDAQ: SCLX) forecast ROA is N/A, which is lower than the forecast US Drug Manufacturers - General industry average of 5.49%.

What is SCLX's Price Target?

According to 1 Wall Street analyst that have issued a 1 year SCLX price target, the average SCLX price target is $12.00, with the highest SCLX stock price forecast at $12.00 and the lowest SCLX stock price forecast at $12.00.

The Wall Street analyst predicted that Scilex Holding Co's share price could reach $12.00 by Dec 4, 2024. The average Scilex Holding Co stock price prediction forecasts a potential upside of 1,293.73% from the current SCLX share price of $0.86.

What is SCLX's forecast return on equity (ROE) for 2024-2026?

(NASDAQ: SCLX) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.